onabotulinum toxin A

01/01/2022 - "In this open label, single-arm trial we evaluated the efficacy of onabotulinum toxin-A in the prevention of high-frequency episodic migraine (8-14 migraine days/month). "
10/01/2023 - "Onabotulinum toxin A is effective in adult chronic migraine, but the efficacy is not well established in adolescent patients. "
03/14/2023 - "Onabotulinum toxin A (OnA) is a well-tolerated and effective treatment for chronic migraine (CM). "
10/01/2023 - "The objective of this study is to describe the safety and efficacy of onabotulinum toxin A and incobotulinum toxin A for adolescent chronic migraine headache. "
11/17/2022 - "Efficacy of Onabotulinum Toxin A on Obsessive-Compulsive Traits in a Population of Chronic Migraine Patients."

10/01/2020 - "Several previous studies on large patient samples have demonstrated the efficacy of Onabotulinum toxin A (OnabotA) on physical symptomatology treatment of headache, but effects on behavioral alterations remain still debate. "
10/01/2023 - "We performed a chart review of adolescents who received onabotulinum toxin A or incobotulinum toxin A for headache prevention. "
02/01/2022 - "A total of 186 patients who were treated with onabotulinum toxin A for cosmetic purposes in our clinic between January 2019 and January 2021 were retrospectively screened, and the clinical and demographic characteristics of the patients who reported headache complaints were examined. "
01/01/2022 - "Onabotulinum toxin-A also reduced the number of headache days (-33.9%, p < 0.01) and the intake of acute medications (-22.9%, p = 0.03). "
08/01/2011 - "No significant differences between onabotulinum toxin A and placebo treatment were detected in the primary (headache days) end point (12.0 vs. 15.9; p = 0.81). "

01/01/2022 - "Intradetrusor injection of Onabotulinum Toxin A (BTX-A) is a third-line treatment for overactive bladder (OAB). "
02/01/2019 - "Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes."
10/01/2014 - "The following data analysis studied the aspects of patient satisfaction following onabotulinum toxin A (BTX-A) treatment including modification of certain parameters, such as frequency of micturition and the use of pads and in particular, the applicability of the international consultation on incontinence questionnaire short form (ICIQ-SF) and the urgency perception scale (UPS) in patients with an overactive bladder (OAB). "
07/01/2014 - "Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder."
11/01/2013 - "This review identifies current evidence for the use of onabotulinum toxin A and sacral nerve neuromodulation for the treatment of overactive bladder in patients who do not respond to optimal medical treatment. "

01/01/2020 - "Interestingly, significant pain improvement was noted in our open label onabotulinum toxin A trial, suggesting a potential placebo effect."
11/01/2018 - "Satisfaction with pain control among onabotulinum toxin A injection patients is high."
01/01/2018 - "OnaBoNT-A intraprostatic injections appeared to be effective and safe to ameliorate symptoms of refractory nonbacterial CP/CPPS; with pain most improved. "
01/01/2020 - "A Randomized, Double-Blind, Controlled Trial Shows that Onabotulinum Toxin A Nerve Blocks do Not Provide Improved Pain Control in Men with Chronic Scrotal Pain."
01/01/2020 - "This randomized, double-blind, controlled trial showed no superiority of onabotulinum toxin A plus local anesthesia over local anesthesia alone for pain control in men with chronic scrotal pain. "

10/01/2020 - "Ultrasound-guided median and ulnar nerve blocks in the forearm to facilitate onabotulinum toxin A injection for palmar hyperhidrosis."
01/01/2020 - "Onabotulinum Toxin A for Sacral and Intergluteal Cleft Hyperhidrosis."
05/01/2013 - "Onabotulinum toxin A injection is an effective third-line treatment for primary focal hyperhidrosis. "
05/01/2013 - "Suture boots: an aid for the injection of onabotulinum toxin a for primary focal hyperhidrosis."
01/01/2021 - "To compare the efficacy of laser-assisted drug delivery of onabotulinum toxin A (BoNTA) and intradermal BoNTA injections in the management of palmar hyperhidrosis. "